Eisai presented latest data regarding drug candidate BAN2401 at CTAD 2020 ...Middle East

PR Newswire - News
Eisai presented latest data regarding drug candidate BAN2401 at CTAD 2020
STOCKHOLM, Nov. 9, 2020 /PRNewswire/ -- BioArctic AB (publ) [Nasdaq Stockholm: BIOA B] announced today data on the drug candidate BAN2401 (lecanemab), which were presented by the company's partner Eisai at the Clinical Trials on Alzheimer's Disease conference (CTAD), November 4-7. The...

Read More Details
Finally We wish PressBee provided you with enough information of ( Eisai presented latest data regarding drug candidate BAN2401 at CTAD 2020 )

Apple Storegoogle play

Also on site :